Archive for the ‘obesity’ tag

MyAlli and Alli Circles Community SM

without comments

normal_MyAlli-HomePage-USA-2009

MyAlli.com is a web portal for people that are either taking Alli, about to start taking it or just thinking about it and wanting to know more. The site has three main sections… More on AdPharm.net

Brand name: Alli
Generic name/category: Orlistat, Antiobesity drugs, Lactones
Company: GlaxoSmithKline (GSK)
Country/Market: USA, North America
Indication(s)/use: Obesity
Target: Consumers (DTC)
Tagline: Success starts here
Medium: Internet
Size/duration: Website / Social Media
Publication/Aired: 2009

To see all of this brand’s ads on AdPharm, click here

Alli in Poland

without comments

AlliPoland

nowosc -
rewolucja w walce z nadwaga

New -
A revolution in the fight against weight

Orlistat (marketed as a prescription under the trade name Xenical by Roche or over-the-counter as Alli by GlaxoSmithKline), also known as tetrahydrolipstatin, is a drug designed to treat obesity. Its primary function is preventing the absorption of fats from the human diet, thereby reducing caloric intake. It is intended for use in conjunction with a physician-supervised reduced-calorie diet. Orlistat is the saturated derivative of lipstatin, a potent natural inhibitor of pancreatic lipases isolated from the bacterium Streptomyces toxytricini. However, due to simplicity and stability, orlistat rather than lipstatin was developed into an anti-obesity drug.

The effectiveness of orlistat in promoting weight loss is definite, though modest. Pooled data from clinical trials suggests that people given orlistat in addition to lifestyle modifications, such as diet and exercise, lose about 2–3 kilograms (4.4–6.6 lb) more than those not taking the drug. Orlistat also modestly reduces blood pressure, and appears to prevent the onset of type 2 diabetes, whether due to weight loss itself or to other effects; in a large randomized controlled trial, orlistat was found to reduce the incidence of diabetes by nearly 40% in obese people.

More on Wikipedia

Brand name: Alli
Generic name/category: Orlistat, Antiobesity drugs, Lactones
Company: GlaxoSmithKline Consumer Healthcare (GSK)
Country/Market: Poland, Europe
Indication(s)/use: obesity
Target: Healthcare Professionals (HCP)
Medium: Print ad
Size/duration: single-page
Publication/Aired: Gazeta Farmaceutyczna – September 2009

To see all of this brand’s ads on AdPharm, click here

Alli in Spain

without comments

ALLISpain

Alli, nueva solución para ayudarte a perder un 50% más de peso.
Alli, a new solution to help you lose 50% more weight.

Orlistat (marketed as a prescription under the trade name Xenical by Roche or over-the-counter as Alli by GlaxoSmithKline), also known as tetrahydrolipstatin, is a drug designed to treat obesity. Its primary function is preventing the absorption of fats from the human diet, thereby reducing caloric intake. It is intended for use in conjunction with a physician-supervised reduced-calorie diet. Orlistat is the saturated derivative of lipstatin, a potent natural inhibitor of pancreatic lipases isolated from the bacterium Streptomyces toxytricini. However, due to simplicity and stability, orlistat rather than lipstatin was developed into an anti-obesity drug.

The effectiveness of orlistat in promoting weight loss is definite, though modest. Pooled data from clinical trials suggests that people given orlistat in addition to lifestyle modifications, such as diet and exercise, lose about 2–3 kilograms (4.4–6.6 lb) more than those not taking the drug. Orlistat also modestly reduces blood pressure, and appears to prevent the onset of type 2 diabetes, whether due to weight loss itself or to other effects; in a large randomized controlled trial, orlistat was found to reduce the incidence of diabetes by nearly 40% in obese people.

More on Wikipedia

Brand name: Alli
Generic name/category: Orlistat, Antiobesity drugs, Lactones
Company: GlaxoSmithKline Consumer Healthcare (GSK)
Country/Market: Spain, Europe
Indication(s)/use: obesity
Target: Consumers (DTC)
Medium: Print ad
Size/duration: single-page
Publication/Aired: Psychologies – August 2009

To see all of this brand’s ads on AdPharm, click here

Alli

without comments

Lose weight the FDA approved way.

FDA approved alli has been used by millions of people to lose weight safely. It’s safe because it works in your digestive tract and doesn’t affect your head or heart. It’s not a stimulant or appetite suppressant. Its a pill you take with each meal that prevents some of the fat you eat from being absorbed.

But Alli is more than a pill, its a comprehensive weight loss plan and support system…


Brand name: Alli
Generic name/category: orlistat, antiobesity drug
Company: GlaxoSmithKline (GSK)
Country/Market: USA, North America
Indication(s)/use: Obesity
Target: Consumers (DTC)
Tagline: Lose weight the FDA approved way
Publication: People Magazine May 25 2009

To see all of this brand’s ads on AdPharm, click here

Realize gastric band

without comments

Why did you become a bariatric surgeon?
So he can walk his daughter down the aisle.

Realize personal banding solution.
Committed to positive patient outcome.

Brand name: Realize
Generic name/category: Gastric band
Company: Ethicon endo-surgery a Johnson&Johnson company
Country/Market: USA, North America
Indication(s)/use: obesity, weight loss
Target: Healthcare Professionals (HCP)
Tagline: Committed to positive patient outcome.
Publication: Bariatric Times January 2009

Another alli success story

without comments

Another alli success story
Join the millions of people losing weight with alli
Connie Degiorgis – 56 pounds lost

Alli. You have the will, we have the power.

Orlistat (marketed under the trade name Xenical by Roche; or over-the-counter as alli by GlaxoSmithKline—also known as tetrahydrolipstatin—is a drug designed to treat obesity. Its primary function is preventing the absorption of fats from the human diet, thereby reducing caloric intake. It is intended for use in conjunction with a physician-supervised reduced-calorie diet.

Orlistat is the saturated derivative of lipstatin—a potent natural inhibitor of pancreatic lipases isolated from the bacterium Streptomyces toxytricini. However, due to simplicity and stability, orlistat rather than lipstatin was developed into an anti-obesity drug. – Wikipedia

Prevention January 2009

Change4life TV commercial

without comments


Click on image to view the commercial

60 active minutes, just one of the ways to change for life (change4life).
Search ‘change4life’ or call 0300 123 4567

Agency: M&C Saatchi
2009